Commercialisation & Medical Affairs

Nicole Dale

Overton FDA Hearing Tests Scientific Independence

Pharmatica image of a receding row of pale columns with one highlighted in vivid red, symbolising scrutiny at the new FDA Commissioner’s confirmation hearing.

Heidi Overton's FDA confirmation hearing exposed sweeping advisory committee cuts, tobacco industry ties, and unclear stances on vaccines and mifepristone policy.

Nicole Dale

What Changes in EMA GVP Module III Revision 2?

Pharmatica image showing a magnifying lens inspecting a connected pharmacovigilance vendor network beside regulatory documents, with vivid red accents.

GVP Module III Revision 2 took effect on 10 September 2026. See what changes for subcontractor oversight, PSMF access, remote inspections, and risk planning.

Nicole Dale

Clinical Trials in Depression Reveal New R&D Priorities in 2026

Pharmatica image representing clinical trials in depression, antidepressant development, patient data, and emerging CNS therapies.

Clinical trials in depression reveal a broader R&D landscape, from antidepressants and NMDA approaches to biological data and precision psychiatry.

Nicole Dale

Ivonescimab Challenges Keytruda Beyond China

Pharmatica image showing global clinical trial pathways connecting Chinese, European, and North American patient populations in ivonescimab development.

Ivonescimab beat pembrolizumab in a Chinese trial. Pharmatica examines what HARMONi-2 means for global clinical development, trial design, and NSCLC treatment.

Nicole Dale

An Overview of EuroQol EQ-5D: Quality-of-Life Assessment

Pharmatica visual of an abstract blue five-bar health scale glowing on a bright background, representing EuroQol EQ-5D quality of life measurement.

EuroQol EQ-5D explained: How it measures quality of life, supports QALYs and HTA decisions, and what new EuroQol tools mean for clinical trial strategy.